Crystal structure of truncated human coatomer protein complex subunit ζ1 (Copζ1)

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Conventional anticancer therapies primarily target proliferating tumor cells, leaving dormant cells unaffected and leading to relapse.
• Human coatomer protein complex I (COPI) subunit ζ (Copζ) is implicated in apoptosis and intracellular trafficking.
• Tumor cells often downregulate Copζ2 expression, relying solely on Copζ1 for survival, unlike normal cells expressing both isoforms.

Purpose of the Study:

• To investigate Copζ1 as a potential therapeutic target for anticancer drug development.
• To facilitate structure-based inhibitor design by obtaining the crystal structure of Copζ1.
• To report the expression and purification of both Copζ1 and Copζ2.

Main Methods:

• Recombinant expression of human Copζ1 and Copζ2.
• Purification of recombinant Copζ1 and Copζ2 proteins.
• Crystallization and X-ray diffraction analysis of Copζ1 to determine its crystal structure.

Main Results:

• Successful recombinant expression and purification of Copζ1 and Copζ2.
• Crystallization of Copζ1 was achieved.
• The crystal structure of Copζ1 was determined, providing a basis for inhibitor design.

Conclusions:

• Copζ1 is a promising therapeutic target for a novel anticancer strategy.
• Targeting Copζ1 can inhibit both proliferating and dormant tumor cells, addressing a key limitation of current therapies.
• The determined crystal structure of Copζ1 is crucial for the rational design of specific anticancer inhibitors.